The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): An in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 2, 2006, Pages 97-104

  Coppell, Jason A ^a   Thalheimer, Ulrich ^a   Zambruni, Andrea ^a   Triantos, Christos K ^a   Riddell, Anne F ^a   Burroughs, Andrew K ^a   Perry, David J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Anti activated factor X activity; Danaparoid; Heparinase; Low molecular weight heparin; Thromboelastography; Unfractionated heparin

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; DALTEPARIN; DANAPAROID; HEPARIN; HEPARIN LYASE; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN; THROMBIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; IN VITRO STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SENSITIVITY ANALYSIS; THROMBIN TIME; THROMBOELASTOGRAPHY;

ADULT; CHONDROITIN SULFATES; DERMATAN SULFATE; FACTOR XA; HEPARIN LYASE; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPARITIN SULFATE; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; THROMBELASTOGRAPHY;

EID: 33646088352     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000203859.62739.25     Document Type: Article

References (36)

1. Hartert H. Blutgerinnung studien mit der thromboelastographie, einen Neuen Untersuchingsverfahren. Wien Klin Wochenschr 1948; 26:577-583.
2. Kettner SC, Gonano C, Seebach F, Sitzwohl C, Acimovic S, Stark J, et al. Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg 1998; 86:691-695.
3. Pivalizza EG, Abramson DC, King FS Jr. Thromboelastography with heparinase in orthotopic liver transplantation. J Cardiothorac Vasc Anesth 1998; 12:305-308.
4. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Anatg 1999; 88:312-319.
5. Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprini JA. Comparison of thrombelastography with common coagulation tests. Thromb Haemost 1981; 46:752-756.
6. Whitten CW, Greilich PE. Thromboelastography: past, present, and future. Anesthesiology 2000; 92:1223-1225.
7. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992; 69:307-313.
8. Klein SM, Slaughter TF, Vail PT, Ginsberg B, El-Moalem HE, Alexander R, et al. Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: a comparison with anti-Xa concentrations. Anesth Analg 2000; 91:1091-1095.
9. Zmuda K, Neofotistos D, Ts'ao CH. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation. Am J Clin Pathol 2000; 113:725-731.
10. Vig S, Chitolie A, Bevan DH, Halliday A, Dormandy J. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis 2001; 12:555-561.
11. Montalto P, Vlachogiannakos J, Cox D, Pastacaldi S, Patch D, Burroughs A. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37:463-470.
12. Nielsen VG. The detection of changes in heparin activity in the rabbit: a comparison of anti-xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time. Anesth Analg 2002; 95:1503-1506.
13. Mancuso A, Fung K, Cox D, Mela M, Patch D, Burroughs AK. Assessment of blood coagulation in severe liver disease using thromboelastography: use of citrate storage versus native blood. Blood Coagul Fibrinolysis 2003; 14:211-216.
14. Zambruni A, Thalheimer U, Coppell J, Riddell A, Mancuso A, Leandro G, et al. Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients. Scand J Gastroenterol 2004; 39:830-836.
15. Salooja N, Perry DJ, Thrombelastography. Blood Coagul Fibrinolysis 2001; 12:327-337.
16. Gibbs NM, Bell R. The effect of low-dose heparin on hypercoagulability following abdominal aortic surgery. Anaesth Intensive Care 1998; 26:503-508.
17. Gibbs NM, Sear JW. Effect of ketorolac, bupivacaine and low-dose heparin on thrombelastographic variables in vitro. Br J Anaesth 1995; 75:27-30.
18. Murray DJ, Brosnahan WJ, Pennell B, Kapalanski D, Weiler JM, Olson J. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth 1997; 11:24-28.
19. Traverso CI, Caprini JA, Arcelus JI, Arcelus IM. Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration. Semin Thromb Hemost 1995; 21(Suppl 4):53-58.
20. Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thrombelastography in liver transplantation. Br J Anaesth 1997; 78:175-179.
21. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86:575-578.
22. Tuman KJ, McCarthy RJ, Djuric M, Rizzo V, Ivankovich AD. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay. J Cardiothorac Vasc Anesth 1994; 8:144-149.
23. Zambruni A, Thalheimer U, Leandro G, Perry D, Burroughs AK. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004; 15:103-107.
24. Caprini JA, Traverse CI, Arcelus JI. Perspectives on thromboelastography. Semin Thromb Hemost 1995; 21(Suppl 4):91-93.
25. Essell JH, Martin TJ, Salinas J, Thompson JM, Smith VC. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993; 7:410-415.
26. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997; 42:716-720; discussion 720-712.
27. Ti LK, Cheong KF, Chen FG. Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth 2002; 16:545-550.
28. McKee RF, Hodson S, Dawes J, Garden OJ, Carter DC. Plasma concentrations of endogenous heparinoids in portal hypertension. Gut 1992; 33:1549-1552.
29. Gerotziafas GT, Chakroun T, Samama MM, Elalamy I. In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile. Thromb Haemost 2004; 92:1296-1302.
30. Jackson CM. Mechanism of heparin action. Baillieres Clin Haematol 1990; 3:483-504.
31. Coccheri S. Low molecular weight heparins: an introduction. Haemostasis 1990; 20(Suppl 1):74-80.
32. Boneu B, Caranobe C, Sie P. Pharmacokinetics of heparin and low molecular weight heparin. Baillieres Clin Haematol 1990; 3:531-544.
33. Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Blood 1984; 64:742-747.
34. Tollefsen DM, Pestka CA, Monafo WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983; 258:6713-6716.
35. Roche AM, James MF, Grocott MP, Mythen MG. Citrated blood does not reliably reflect fresh whole blood coagulability in trials of in vitro hemodilution. Anesth Analg 2003; 96:58-61.
36. Camenzind V, Bombeli T, Seifert B, Jamnicki M, Popovic D, Pasch T, et al. Citrate storage affects Thrombelastograph analysis. Anesthesiology 2000; 92:1242-1249.